Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,156 | 4,463 | 7,324 | 2,340 | 23,736 |
| Marketable Securities | 18,845 | 20,862 | 20,486 | 21,547 | 2,250 |
| Receivables | 379 | 346 | 385 | 388 | 165 |
| Other current assets | 0 | 0 | 0 | 6,000 | 6,000 |
| TOTAL | $23,380 | $25,671 | $28,195 | $30,275 | $32,151 |
| Non-Current Assets | |||||
| PPE Net | 883 | 902 | 915 | 773 | 774 |
| TOTAL | $883 | $902 | $915 | $773 | $774 |
| Total Assets | $24,263 | $26,573 | $29,110 | $31,048 | $32,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,541 | 1,326 | 1,501 | 1,356 | 1,118 |
| TOTAL | $2,541 | $1,326 | $1,501 | $1,356 | $1,118 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 177 | 187 | 194 | 205 | 400 |
| TOTAL | $177 | $187 | $194 | $205 | $400 |
| Total Liabilities | $2,718 | $1,513 | $1,695 | $1,561 | $1,518 |
| Shareholders' Equity | |||||
| Common Shares | 32 | 32 | 32 | 32 | 32 |
| Retained earnings | -47,367 | -44,162 | -41,562 | -39,208 | -36,745 |
| Other shareholders' equity | -206 | -56 | -61 | -11 | 4 |
| TOTAL | $21,545 | $25,060 | $27,415 | $29,487 | $31,407 |
| Total Liabilities And Equity | $24,263 | $26,573 | $29,110 | $31,048 | $32,925 |